GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Global Pharmatech Inc (OTCPK:GBLP) » Definitions » Net Income From Continuing Operations

Global Pharmatech (Global Pharmatech) Net Income From Continuing Operations : $-3.09 Mil (TTM As of Jun. 2008)


View and export this data going back to . Start your Free Trial

What is Global Pharmatech Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Global Pharmatech's net income from continuing operations for the three months ended in Jun. 2008 was $-0.09 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2008 was $-3.09 Mil.

Global Pharmatech Net Income From Continuing Operations Historical Data

The historical data trend for Global Pharmatech's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Pharmatech Net Income From Continuing Operations Chart

Global Pharmatech Annual Data
Trend Mar03 Mar04 Dec05 Dec06 Dec07
Net Income From Continuing Operations
- - 0.20 -1.23 -3.30

Global Pharmatech Quarterly Data
Mar03 Mar04 Sep04 Dec04 Mar05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -1.28 -1.50 -0.21 -0.09

Global Pharmatech Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Pharmatech (Global Pharmatech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Global Pharmatech Inc (OTCPK:GBLP) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:524661 BOM:531686 BOM:524322 BOM:524516 HSTI BOM:524572 XCNQ:WRW TSXV:CIP.H XCNQ:DYME BOM:524606 BKIT YBAO BOM:526075 BOM:531541 BOM:524604 BOM:533157 BOM:531762 BOM:524400 XCNQ:MJRX BOM:531210
Traded in Other Exchanges
N/A
Address
No. 75, Fa Yuen Street, Mong Kok, Flat/RM 705, 7/F, Fa Yuen Commercial Building, Hong Kong, HKG
Website
http://www.global-pharmatech.com
Global Pharmatech Inc through its subsdiaries, discovers, develops, manufactures and markets proprietary drugs developed based on Traditional Chinese Medicine (TCM) while utilizing modern facilities and advanced R&D technologies. Geographically, the major business activities are carried out through People's Republic of China with sales distribution in China, Hong Kong, Singapore, Malaysia, Indonesia and USA.

Global Pharmatech (Global Pharmatech) Headlines

No Headlines